LENALIDOMID Teva caps 5 mg 21 pce
7680674600022
CH-67460
L04AX04
07.16.4.
Reimbursement limitations:
LENALI.TE.09
LENALIDOMID-TEVA en association avec l’ixazomib et la dexaméthasone
Après accord sur la prise en charge …
1 / 3
google
Details
- Product number
- 6746002
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- lenalidomidum 5 mg ut lenalidomidi hydrochloridum monohydricum, silica colloidalis anhydrica, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.012 mg, talcum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula.
Articles (1)
Lenalidomid-Teva 5 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.012 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 786.15
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2022
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67460
- Drug name
- Lenalidomid-Teva, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/11/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LENALIDOMID Teva caps 5 mg 21 pce
- Description (DE)
- LENALIDOMID Teva Kaps 5 mg 21 Stk
- Market launch
- 05/11/2019
- Narcotic (BTM)
- No